Health and medicine
Partnership to make 120 million COVID-19 rapid tests available to lower-income countries
Agreements with Abbott and SD Biosensor will provide up to 120 million antigen tests over six months at no more than $5 each. The Global Fund has committed an initial $50 million to help countries buy them.